Related Experiment Video
Updated: Mar 20, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Cofilin-1 is a redox-sensitive guard of the NLRP3 inflammasome
Yong Hwan Park1,2,3,4, Ezgi D Batu1, Brynja Matthiasardottir1,5
1Inflammatory Disease Section, Medical Genetics Branch, National Human Genome Research Institute, Bethesda, MD, USA.
Abstract:
Mutations in NLRP3 can cause a spectrum of the autoinflammatory cryopyrin-associated periodic syndromes (CAPS). Reactive oxygen species (ROS) have a central role in NLRP3 inflammasome activation. Here we show that cofilin-1, an actin-severing protein, is a negative regulator of the NLRP3 inflammasome. In resting cells, cofilin-1 directly bound NLRP3, but after stimulation with NLRP3 inflammasome activators, it was oxidized by ROS and dissociated from NLRP3. CAPS-associated mutant NLRP3 exhibited reduced binding to cofilin-1. Residues 101-104 of cofilin-1 were critical for NLRP3 interaction. Oxidation-independent peptides containing this NLRP3 binding motif suppressed inflammasome activation induced by endogenous CAPS-associated mutations and ex vivo NLRP3 activators such as ATP and nigericin. Bioinformatic structural analyses corroborate a model in which cofilin-1 has a pivotal function in NLRP3 activation by ROS and support the potential use of cofilin-1-derived peptides in individuals who are unresponsive to or intolerant of other forms of NLRP3 blockade.
Insights
Cofilin-1 negatively regulates the NLRP3 inflammasome, a key player in autoinflammatory diseases. Peptides derived from cofilin-1 show potential for treating cryopyrin-associated periodic syndromes (CAPS).
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Cryopyrin-associated periodic syndromes (CAPS) are autoinflammatory diseases caused by NLRP3 mutations.
- Reactive oxygen species (ROS) are crucial for NLRP3 inflammasome activation.
Purpose of the Study:
- To investigate the role of cofilin-1 as a regulator of the NLRP3 inflammasome.
- To explore the therapeutic potential of cofilin-1-derived peptides for CAPS.
Main Methods:
- Protein binding assays to assess cofilin-1 and NLRP3 interaction.
- ROS-mediated oxidation studies of cofilin-1.
- Peptide-based inhibition assays using NLRP3 activators and CAPS models.
- Bioinformatic structural analyses.
Main Results:
- Cofilin-1 directly binds NLRP3 in resting cells and dissociates upon ROS-induced oxidation.
- CAPS-associated NLRP3 mutants show decreased binding to cofilin-1.
- Specific cofilin-1 residues (101-104) are critical for NLRP3 interaction.
- Oxidation-independent cofilin-1 peptides suppressed inflammasome activation in vitro and in CAPS models.
Conclusions:
- Cofilin-1 acts as a negative regulator of NLRP3 inflammasome activation, modulated by ROS.
- Cofilin-1-derived peptides represent a promising therapeutic strategy for patients with CAPS, particularly those unresponsive to existing treatments.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Mechanism of Filopodia Formation
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Regulation of Nuclear Protein Sorting
NF-kB-dependent Signaling Pathway
Regulation of the Unfolded Protein Response

